317 related articles for article (PubMed ID: 25946082)
1. Fluorescence guided resection and glioblastoma in 2015: A review.
Leroy HA; Vermandel M; Lejeune JP; Mordon S; Reyns N
Lasers Surg Med; 2015 Jul; 47(5):441-51. PubMed ID: 25946082
[TBL] [Abstract][Full Text] [Related]
2. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
Colditz MJ; Jeffree RL
J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
[TBL] [Abstract][Full Text] [Related]
3. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
4. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Surgery of High-Grade Gliomas: A Systematic Review.
Guyotat J; Pallud J; Armoiry X; Pavlov V; Metellus P
Adv Tech Stand Neurosurg; 2016; (43):61-90. PubMed ID: 26508406
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors.
Johansson A; Palte G; Schnell O; Tonn JC; Herms J; Stepp H
Photochem Photobiol; 2010; 86(6):1373-8. PubMed ID: 20854414
[TBL] [Abstract][Full Text] [Related]
7. Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
Suero Molina E; Wölfer J; Ewelt C; Ehrhardt A; Brokinkel B; Stummer W
J Neurosurg; 2018 Feb; 128(2):399-405. PubMed ID: 28338432
[TBL] [Abstract][Full Text] [Related]
8. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
9. Selective 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in Gliomas.
Ma R; Watts C
Acta Neurochir (Wien); 2016 Oct; 158(10):1935-41. PubMed ID: 27496021
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic Acid: Pitfalls of Fluorescence-guided Resection for Malignant Gliomas and Application for Malignant Glioma Therapy.
Yamamoto J; Kitagawa T; Miyaoka R; Suzuki K; Takamatsu S; Saito T; Nakano Y
J UOEH; 2020; 42(1):27-34. PubMed ID: 32213740
[TBL] [Abstract][Full Text] [Related]
11. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 2: theoretical, biochemical and practical aspects.
Colditz MJ; Leyen Kv; Jeffree RL
J Clin Neurosci; 2012 Dec; 19(12):1611-6. PubMed ID: 23059058
[TBL] [Abstract][Full Text] [Related]
12. δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy.
Valdés PA; Kim A; Brantsch M; Niu C; Moses ZB; Tosteson TD; Wilson BC; Paulsen KD; Roberts DW; Harris BT
Neuro Oncol; 2011 Aug; 13(8):846-56. PubMed ID: 21798847
[TBL] [Abstract][Full Text] [Related]
13. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
14. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract][Full Text] [Related]
15. Low dose 5-aminolevulinic acid: Implications in spectroscopic measurements during brain tumor surgery.
Haj-Hosseini N; Richter JC; Hallbeck M; Wårdell K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):209-14. PubMed ID: 25818546
[TBL] [Abstract][Full Text] [Related]
16. Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma.
Liu Z; Mela A; Argenziano MG; Banu MA; Furnari J; Kotidis C; Sperring CP; Humala N; Mahajan A; Bruce JN; Canoll P; Sims PA
J Neurosurg; 2024 Apr; 140(4):968-978. PubMed ID: 37773782
[TBL] [Abstract][Full Text] [Related]
17. A surgical loupe system for observing protoporphyrin IX fluorescence in high-grade gliomas after administering 5-aminolevulinic acid.
Kuroiwa T; Kajimoto Y; Furuse M; Miyatake S
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):379-81. PubMed ID: 24284089
[TBL] [Abstract][Full Text] [Related]
18. [5-Aminolevulinic acid (ALA) and its applications in neurosurgery].
Grieb P
Neurol Neurochir Pol; 2004; 38(3):201-7. PubMed ID: 15354233
[TBL] [Abstract][Full Text] [Related]
19. [Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients].
Jacquesson T; Ducray F; Maucort-Boulch D; Armoiry X; Louis-Tisserand G; Mbaye M; Pelissou-Guyotat I; Guyotat J
Neurochirurgie; 2013 Feb; 59(1):9-16. PubMed ID: 23318102
[TBL] [Abstract][Full Text] [Related]
20. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
